TABLE 3.
Patients’ postoperative data and outcomes.
| DCD Group (n = 11) | DBD Group (n = 110) | p-value | |
|---|---|---|---|
| Grade 3 PGD, n (%) | 3 (27.3) | 20 (18.2) | 0.724 |
| MV (days), median (IQR) | 2.0 (2.5) | 1.0 (2.0) | 0.011* |
| ICU stay (days), median (IQR) | 4.0 (5.5) | 3.0 (3.0) | 0.053 |
| Hospital stay (days), median (IQR) | 21 (5) | 22 (10) | 0.732 |
| Airway complication, n (%) | 2 (18.2) | 7 (6.4) | 0.154 |
| 90-days mortality | 0 (0.0) | 5 (4.6) | 0.999 |
| ALAD, n (%) | 3 (27.3) | 34 (30.9) | 0.999 |
| Histologic AR a , n (%) | |||
| Grade 0 | 4 (36.3) | 28 (28) | 0.561 |
| Grade 1 | 5 (45.5) | 56 (56) | 0.505 |
| Grade 2 | 2 (18.2) | 14 (14) | 0.708 |
| Grade 3 | 0 (0.0) | 2 (2) | 0.636 |
a
AR was calculated in 11 DCD and 100 DBD.
IQR, interquartile range; PGD, primary graft dysfunction; MV, mechanical ventilation; ICU, intensive care unit; ALAD, acute lung allograft dysfunction; AR, acute rejection.